Comparative Efficacy of Water & Indigo Carmine vs. Water or Air Method on Adenoma Detection Rate (ADR) - a Randomized Controlled Trial (RCT)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Adenoma detection rate (ADR) is a quality indicator of colonoscopy performed for colorectal cancer screening. Population studies have shown that traditional air colonoscopy fails to eliminate post screening colonoscopy cancers or cancer mortality in the proximal colon. The investigators aim to establish the superior effectiveness of combining chromoendoscopy with the water exchange method in detecting more proximal diminutive adenomas during screening colonoscopy in sedated veterans. An improved adenoma detection rate associated with optical colonoscopy will minimize the risk of missed lesions. The improvement may translate into a remedy for the limitations of screening colonoscopy in the proximal colon, e.g. a higher adenoma detection rate may minimize the burden of post screening colonoscopy interval colorectal cancers among the veteran population.
| Condition | Intervention |
|---|---|
|
Colorectal Neoplasms |
Drug: Indigo carmine Procedure: water (exchange) method Procedure: water (exchange) plus dye method Procedure: air method |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Comparative Efficacy of Water & Indigo Carmine vs Water or Air Method |
- Proximal diminutive (<10 mm) adenoma detection rate [ Time Frame: 36 months ] [ Designated as safety issue: No ]Proximal diminutive adenoma detection rate (ADR) in screening colonoscopy performed with the unusual air method, versus the water (exchange) method and with dye added to the water (exchange) method
| Estimated Enrollment: | 480 |
| Study Start Date: | January 2013 |
| Estimated Study Completion Date: | September 2015 |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: water (exchange) method
Residual pocket of air will be suctioned. Water is infused using a peristaltic pump to facilitate scope advancement until the cecum is reached. Dirty water will be suctioned and clean water is infused. Air will not be insufflated until the cecum is reached. Residual water is suctioned and air insufflated on scope withdrawal to facilitate biopsy and removal of lesions.
|
Procedure: water (exchange) method
Residual pocket of air will be suctioned. Water is infused using a peristaltic pump to facilitate scope advancement until the cecum is reached. Dirty water will be suctioned and clean water is infused. Air will not be insufflated until the cecum is reached. Residual water is suctioned and air insufflated on scope withdrawal to facilitate biopsy and removal of lesions.
|
|
Experimental: water (exchange) plus dye method
Residual pocket of air will be suctioned. Water with 0.008% indigocarmine is infused using a peristaltic pump to facilitate scope advancement until the cecum is reached. Dirty water will be suctioned and clean water is infused. Air will not be insufflated until the cecum is reached. Residual water is suctioned and air insufflated on scope withdrawal to facilitate biopsy and removal of lesions
|
Drug: Indigo carmine
0.008% indigo carmine in water is used as a surface contrast agent to enhance visualization of diminutive polyps (adenoma) during screening colonoscopy
Procedure: water (exchange) plus dye method
Residual pocket of air will be suctioned. Water with 0.008% indigocarmine is infused using a peristaltic pump to facilitate scope advancement until the cecum is reached. Dirty water will be suctioned and clean water is infused. Air will not be insufflated until the cecum is reached. Residual water is suctioned and air insufflated on scope withdrawal to facilitate biopsy and removal of lesions
|
|
Active Comparator: air method
The colonoscope is inserted gently and advanced slowly using minimal air insufflation, if necessary, the assistant will provide abdominal compression or the patient's position will be changed to facilitate scope passage. The scope is inserted until the cecum is reached. Air is insufflated on scope withdrawal for visualization and water irrigation is used to remove any adherent feces covering the mucosa. Biopsy or polypectomy is performed where indicated.
|
Procedure: air method
The colonoscope is inserted gently and advanced slowly using minimal air insufflation, if necessary, the assistant will provide abdominal compression or the patient's position will be changed to facilitate scope passage. The scope is inserted until the cecum is reached. Air is insufflated on scope withdrawal for visualization and water irrigation is used to remove any adherent feces covering the mucosa. Biopsy or polypectomy is performed where indicated.
|
Detailed Description:
- Design: Prospective, single center, patient blinded, randomized controlled trial
Methods: Colonoscopy with traditional air insufflation, water exchange or water exchange plus indigocarmine to aid insertion of colonoscope; split dose bowel preparation; all patients will receive sedation; assessment of serum electrolytes level before and after colonoscopy
- Control method: Traditional air insufflation method.
Study methods:
- Water exchange method.
- Water method combined with chromoendoscopy (0.008% indigo carmine).
- Population to be studied Veterans between age 50 and 75 referred for first time screening colonoscopy
Unit(s) of analysis
- Primary outcome: overall adenoma detection rate.
- Secondary outcomes: patient demographic variable and procedure related measures.
Sampling strategy: all veterans referred for screening colonoscopy will be offered enrollment in the study.
- Sample size calculation. A total of 480 subjects will be recruited and randomized with 160 in each group.
5. Subject recruitment: patients referred for screening colonoscopy come from three sources.
6. Description of base population and groups to be studied and method of randomization.
Veterans between age 50 and 75 referred for first time screening colonoscopy. After informed consent, assignment to control or study arm based on computer generated random number codes stored in pre-arranged opaque envelopes.
Eligibility| Ages Eligible for Study: | 45 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- asymptomatic veterans scheduled for first time screening colonoscopy and agree to be randomized will be enrolled.
Exclusion Criteria:
- patients who decline to be randomized, non screening cases.
Contacts and Locations| Contact: Joseph W Leung | (916) 366-5339 | Joseph.Leung2@va.gov |
| Contact: Felix W Leung | (818) 891-7711 | Felix.Leung@va.gov |
| United States, California | |
| VA Northern California Health Care System, Mather, CA | Not yet recruiting |
| Sacramento, California, United States, 95655 | |
| Contact: Joseph W Leung 916-366-5339 Joseph.Leung2@va.gov | |
| Contact: Andrew Yen, MD (916) 366-5339 Andrew.Yen3@va.gov | |
| Principal Investigator: Joseph W. Leung | |
| Principal Investigator: | Joseph W. Leung | VA Northern California Health Care System, Mather, CA |
More Information
Publications:
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT01607255 History of Changes |
| Other Study ID Numbers: | CLIN-10-11S |
| Study First Received: | May 24, 2012 |
| Last Updated: | November 27, 2012 |
| Health Authority: | United States: Federal Government United States: Food and Drug Administration |
Keywords provided by Department of Veterans Affairs:
|
adenoma detection screening colonoscopy water exchange method chromoendoscopy |
Additional relevant MeSH terms:
|
Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 19, 2013